Cargando…
C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis
Background: The discovery of reliable cancer biomarkers could tune a diagnosis and improve the way patients are treated. However, many cancers lack robust biomarkers. C1QTNF6 has been preliminarily elucidated for its role in some tumors. However, no pan-cancer analysis has been performed to comprehe...
Autores principales: | Liu, Wei, Zhang, Jian, Xie, Tao, Huang, Xiaoting, Wang, Baiyao, Tian, Yunhong, Yuan, Yawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985594/ https://www.ncbi.nlm.nih.gov/pubmed/35401204 http://dx.doi.org/10.3389/fphar.2022.855485 |
Ejemplares similares
-
A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration
por: Du, Kunpeng, et al.
Publicado: (2022) -
Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators
por: Zhang, Jian, et al.
Publicado: (2021) -
A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma
por: Du, Kunpeng, et al.
Publicado: (2022) -
Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022) -
Expression of a Secretory Protein C1qTNF6, a C1qTNF Family Member, in Hepatocellular Carcinoma
por: Takeuchi, Tamotsu, et al.
Publicado: (2011)